Acquired factor VIII (FVIII) deficiency, also known as acquired hemophilia A (AHA), is a rare entity in which antibodies target FVIII, causing severe and potentially fatal bleeding [1]. The gene discussed is F8; the disease is autoimmune hemolytic anemia.